Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Deceased Donor Kidney Transplant”

75 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 75 results

Testing effectiveness (Phase 2)Looking for participantsNCT06919003
What this trial is testing

Improving Deceased-Donor Kidney Transplant Outcomes Via a Single Intragraft Injection of C1 Esterase Inhibitor (IMPROVE TRIAL)

Who this might be right for
Kidney Transplant
National Institute of Allergy and Infectious Diseases (NIAID) 180
Post-approval studies (Phase 4)Study completedNCT00685061
What this trial is testing

Thymoglobulin Versus Campath-1H Versus Daclizumab in Adult, Primary Deceased Donor Renal Transplantation

Who this might be right for
Renal Transplantation
University of Miami 90
Testing effectiveness (Phase 2)Study completedNCT02134314
What this trial is testing

C1INH Inhibitor Preoperative and Post Kidney Transplant to Prevent DGF & IRI

Who this might be right for
End Stage Renal DiseaseKidney FailureDelayed Graft Function+1 more
Cedars-Sinai Medical Center 70
Not applicableEnrolling By InvitationNCT06510101
What this trial is testing

Manual Manipulation and Ex Vivo Flexible Ureteroscopic Lithotripsy to Salvage Deceased Donor Kidneys With Renal Stones: A Case Series

Who this might be right for
Manual Manipulation and Ex Vivo Flexible Ureteroscopic Lithotripsy to Salvage Deceased Donor Kidneys With Renal Stones:a New Method by
Yingxin FU.MD 9
Not applicableLooking for participantsNCT06759831
What this trial is testing

Clinical and Immunological Outcomes of Living and Deceased Donor Transplantation

Who this might be right for
Transplant Recipient (Kidney)
IRCCS Azienda Ospedaliero-Universitaria di Bologna 1,293
Large-scale testing (Phase 3)Active Not RecruitingNCT05369975
What this trial is testing

Efficacy and Safety in Imlifidase Desensitized Kidney Tx Patients, Including Two Non-Comparative Reference Cohorts

Who this might be right for
Kidney Transplantation in Highly Sensitized Patients
Hansa Biopharma AB 225
Not applicableStudy completedNCT03378817
What this trial is testing

Hypothermic Oxygenated Machine Perfusion of Extended Criteria Kidney Allografts From Brain Death Donors

Who this might be right for
Reperfusion InjuryHypothermic Oxygenated Machine Perfusion
University Hospital, Aachen 45
Post-approval studies (Phase 4)Study completedNCT02152345
What this trial is testing

Belatacept Compared to Tacrolimus in Deceased Donor Renal Transplant Recipients

Who this might be right for
Implant or Graft; Rejection
Columbia University 57
Post-approval studies (Phase 4)Study completedNCT02907554
What this trial is testing

Cyclosporine a Pretreatment and Kidney Graft Function

Who this might be right for
Brain DeathKidney Transplantation
University Hospital, Clermont-Ferrand 648
Testing effectiveness (Phase 2)WithdrawnNCT04174677
What this trial is testing

Safety and Tolerability of Inebilizumab, VIB4920, or the Combination in Highly Sensitized Candidates Awaiting Kidney Transplantation From a Deceased Donor

Who this might be right for
Highly Sensitized Patients on Waiting List for Kidney Transplantation
Amgen
Not applicableStudy completedNCT01976390
What this trial is testing

Comparing Everolimus and Sirolimus in Renal Transplant Recipients

Who this might be right for
Renal Failure
Ohio State University 60
Testing effectiveness (Phase 2)Study completedNCT01567085
What this trial is testing

Safety & Efficacy Of Eculizumab In The Prevention Of AMR In Sensitized Recipients Of A Kidney Transplant From A Deceased Donor

Who this might be right for
Stage V Chronic Kidney Disease
Alexion Pharmaceuticals, Inc. 80
Large-scale testing (Phase 3)UnknownNCT02474667
What this trial is testing

Reduce the Severity of DGF in Recipients of a Deceased Donor Kidney

Who this might be right for
Delayed Graft Function
Angion Biomedica Corp 253
Testing effectiveness (Phase 2)Ended earlyNCT00167661
What this trial is testing

Campath-1H Induction to Allow Steroid Free Immunosuppression in Pediatric Renal Transplantation

Who this might be right for
Disorder Related to Renal Transplantation
University of Wisconsin, Madison 33
Not applicableStudy completedNCT03098706
What this trial is testing

Therapeutic Hypothermia in "Expanded Criteria" Brain-dead Donors and Kidney-graft Function

Who this might be right for
Organ DonorBrain DeathKidney Transplant; Complications+2 more
Nantes University Hospital 532
Not applicableStudy completedNCT02750397
What this trial is testing

HIV-to-HIV Transplant at MGH

Who this might be right for
HIVAwaiting Organ Transplant
Massachusetts General Hospital 13
Not applicableActive Not RecruitingNCT07385651
What this trial is testing

Deceased Donor Kidney Storage at 10 Celsius Versus Conventional Storage

Who this might be right for
End Stage Chronic Renal FailureChronic Kidney Disease (Stages 4 and 5)Kidney Transplantation Recipients
Vanderbilt University Medical Center 30
Testing effectiveness (Phase 2)Active Not RecruitingNCT05148715
What this trial is testing

Calcineurin Inhibitor in NEuRoloGically Deceased Donors to Decrease Kidney delaYed Graft Function (CINERGY)

Who this might be right for
Organ Transplant Failure or RejectionBrain DeathIschemic Reperfusion Injury
Université de Sherbrooke 414
Testing effectiveness (Phase 2)Active Not RecruitingNCT05907096
What this trial is testing

ARGX-117 in Deceased Donor Kidney Transplant Recipients at Risk for Delayed Graft Function

Who this might be right for
Delayed Graft Function
argenx 103
Large-scale testing (Phase 3)Study completedNCT03829488
What this trial is testing

Better Evidence for Selecting Transplant Fluids

Who this might be right for
End Stage Kidney DiseaseDelayed Graft FunctionKidney Transplant; Complications
The University of Queensland 808
Load More Results